Market Overview

5 Reasons The Prognosis For Acadia Healthcare Just Got Worse

Share:
5 Reasons The Prognosis For Acadia Healthcare Just Got Worse

Shares of Acadia Healthcare Company Inc (NASDAQ: ACHC) plummeted 25 percent after the behavioral healthcare services company with operations in the U.S. and U.K. reported disappointing third-quarter earnings.

In reaction to the earnings report, Baird's Whit Mayo downgraded Acadia's stock from Outperform to Neutral with a price target lowered from $55 to $38.

  1. Acadia Healthcare acknowledged its U.K. performance in September was unusually soft amid higher agency costs and a tightening labor market, the analyst wrote in a note. Moreover, the country's entire healthcare system is seeing "accelerated challenges" that are likely "magnified" from the 2016 Brexit vote.
  2. The stock's forward multiple has been stuck in a range of approximately 10x to 12x EV/EBITDA and there's no reason to justify a multiple of 10x or better.
  3. A string of stock sales from insider will prove to be a "sticking point" for investors.
  4. A recurring factor, Acadia Healthcare is overly ambitious estimates from Wall Street. This was the case in the third quarter earnings report where the company's revenue of $717 million was 1.3 percent short of expectations and EBITDa of $152 million was 6.5 percent. Meanwhile, initial estimates for 2018 will likely prove to be "too ambitious" and on the high side.
  5. The company's growth strategy has been based on acquiring and integrating new behavioral health facilities and moving forward new M&A deals will likely prove to be "less rewarding."

Related Links:

Benzinga's Top Upgrades, Downgrades For October 25, 2017

7 Health Care Names Worth Owning In The Trump Age

Latest Ratings for ACHC

DateFirmActionFromTo
Sep 2019MaintainsNeutral
Jul 2019DowngradesStrong BuyOutperform
May 2019MaintainsMarket PerformMarket Perform

View More Analyst Ratings for ACHC
View the Latest Analyst Ratings

Posted-In: Baird Brexit Health stocks healthcareAnalyst Color Downgrades Price Target Analyst Ratings Best of Benzinga

 

Related Articles (ACHC)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
MUCascendReiterates65.0
ALDRCanaccord GenuityDowngrades20.0
LEGHLake StreetInitiates Coverage On21.0
CHUGoldman SachsUpgrades13.2
STZBMO CapitalMaintains230.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

AT&T's 2018 Potential Makes Near-Term Weakness Worth It

Mid-Morning Market Update: Markets Mostly Lower; Coca-Cola Tops Q3 Estimates